Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mueller

Showing results (511-520 of 688) with videos related to

Pageof 69
Sort By:
Physical Review Letters|February 1, 2008
Nuclear charge radius of 8HeP Mueller, I A Sulai, A C C Villari, et al.
Scientific Reports|September 19, 2015
Corrigendum: Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerasesGregory S Basarab, Gunther H Kern, John McNulty, et al.
Genetics|January 6, 2018
An Expanded Role for the RFX Transcription Factor DAF-19, with Dual Functions in Ciliated and Nonciliated NeuronsElizabeth A De Stasio, Katherine P Mueller, Rosemary J Bauer, et al.
Scientific Reports|July 15, 2015
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerasesGregory S Basarab, Gunther H Kern, John McNulty, et al.
Environmental Science & Technology|July 3, 2025
The Clumped Isotope Signatures of Multiple Methanogenic MetabolismsJiawen Li, Jeanine L Ash, Alec Cobban, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Research Square|November 21, 2023
FOXO1 is a master regulator of CAR T memory programmingAlexander Doan, Katherine P Mueller, Andy Chen, et al.
Lancet (London, England)|December 14, 2025
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trialAlison Luckey, Manica Balasegaram, Lindley A Barbee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialM Sieber, H Tesch, B Pfistner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diolsMark E Flanagan, Steven J Brickner, Manjinder Lall, et al.
Pageof 69

Showing results (511-520 of 688) with videos related to

Sort By:
Pageof 69
Physical Review Letters|February 1, 2008
Nuclear charge radius of 8HeP Mueller, I A Sulai, A C C Villari, et al.
Scientific Reports|September 19, 2015
Corrigendum: Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerasesGregory S Basarab, Gunther H Kern, John McNulty, et al.
Genetics|January 6, 2018
An Expanded Role for the RFX Transcription Factor DAF-19, with Dual Functions in Ciliated and Nonciliated NeuronsElizabeth A De Stasio, Katherine P Mueller, Rosemary J Bauer, et al.
Scientific Reports|July 15, 2015
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerasesGregory S Basarab, Gunther H Kern, John McNulty, et al.
Environmental Science & Technology|July 3, 2025
The Clumped Isotope Signatures of Multiple Methanogenic MetabolismsJiawen Li, Jeanine L Ash, Alec Cobban, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Research Square|November 21, 2023
FOXO1 is a master regulator of CAR T memory programmingAlexander Doan, Katherine P Mueller, Andy Chen, et al.
Lancet (London, England)|December 14, 2025
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trialAlison Luckey, Manica Balasegaram, Lindley A Barbee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trialM Sieber, H Tesch, B Pfistner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diolsMark E Flanagan, Steven J Brickner, Manjinder Lall, et al.
Pageof 69